Jaguar Animal Health(DE:1JA2)
€99,225.000.00 (0.00%)
DE:1JA2
Jaguar Animal Health financials statements
€99,225.00
At close:0.00 (0.00%)
Jaguar Animal Health (1JA2) Ratios
0 Followers
Jaguar Animal Health Ratios
DE:1JA2's free cash flow for Q2 2026 was $-5.34M. For the 2026 fiscal year, DE:1JA2's free cash flow was increased by $0.00 and operating cash flow was $-5.34M. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.50 | 1.63 | 2.00 | 0.74 | 1.84 |
| Quick Ratio | 0.29 | 1.11 | 1.34 | 0.50 | 1.52 |
| Cash Ratio | 0.02 | 0.41 | 0.46 | 0.18 | 1.10 |
| Solvency Ratio | -0.90 | -0.77 | -0.88 | -0.93 | -1.23 |
| Operating Cash Flow Ratio | -0.58 | -1.49 | -2.38 | -1.09 | -2.26 |
| Short-Term Operating Cash Flow Coverage | -0.86 | -2.44 | -6.83 | -2.08 | -10.98 |
| Net Current Asset Value | $ -36.67M | $ -14.73M | $ -17.90M | $ -26.49M | $ -12.98M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 1.14 | 0.68 | 0.73 | 0.73 | 0.55 |
| Debt-to-Equity Ratio | -2.52 | 5.01 | 7.48 | -53.02 | 2.53 |
| Debt-to-Capital Ratio | 1.66 | 0.83 | 0.88 | 1.02 | 0.72 |
| Long-Term Debt-to-Capital Ratio | -6.84 | 0.76 | 0.86 | 1.04 | 0.68 |
| Financial Leverage Ratio | -2.22 | 7.33 | 10.23 | -72.23 | 4.59 |
| Debt Service Coverage Ratio | -1.89 | -2.99 | -2.91 | -1.17 | -3.65 |
| Interest Coverage Ratio | 673.25 | -133.47 | -5.37 | -2.70 | -4.83 |
| Debt to Market Cap | 19.58 | 4.78 | 30.70 | 882.47 | 136.29 |
| Interest Debt Per Share | 9799.68 | 4368.03 | 2819.27 | 4067103.76 | 7120477.39 |
| Net Debt to EBITDA | -0.82 | -0.78 | -0.93 | -0.88 | -0.29 |
| Profitability Margins | |||||
| Gross Profit Margin | 67.21% | 83.27% | 79.13% | 83.11% | 46.18% |
| EBIT Margin | -468.51% | -333.82% | -347.51% | -298.36% | -1019.12% |
| EBITDA Margin | -449.38% | -313.65% | -335.62% | -279.19% | -977.30% |
| Operating Profit Margin | -391.87% | -263.76% | -351.31% | -287.85% | -939.05% |
| Pretax Profit Margin | -469.09% | -335.79% | -429.27% | -404.78% | -1213.38% |
| Net Profit Margin | -464.20% | -329.30% | -423.11% | -396.91% | -1213.26% |
| Continuous Operations Profit Margin | -469.09% | -335.79% | -429.27% | -404.78% | -1213.38% |
| Net Income Per EBT | 98.96% | 98.07% | 98.57% | 98.06% | 99.99% |
| EBT Per EBIT | 119.71% | 127.31% | 122.19% | 140.62% | 129.21% |
| Return on Assets (ROA) | -139.43% | -72.05% | -81.36% | -100.00% | -98.74% |
| Return on Equity (ROE) | 309.06% | -528.37% | -832.49% | 7222.83% | -452.98% |
| Return on Capital Employed (ROCE) | 1935.14% | -91.43% | -93.24% | -201.10% | -107.71% |
| Return on Invested Capital (ROIC) | -178.29% | -66.94% | -81.66% | -102.80% | -98.76% |
| Return on Tangible Assets | -239.59% | -110.15% | -134.76% | -189.72% | -171.80% |
| Earnings Yield | -2460.17% | -517.59% | -3535.53% | -124532.71% | -25413.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.78 | 7.10 | 4.47 | 4.85 | 2.02 |
| Payables Turnover | 0.43 | 0.37 | 0.41 | 0.35 | 0.47 |
| Inventory Turnover | 0.44 | 0.19 | 0.22 | 0.29 | 0.48 |
| Fixed Asset Turnover | 7.87 | 8.35 | 5.84 | 7.05 | 2.50 |
| Asset Turnover | 0.30 | 0.22 | 0.19 | 0.25 | 0.08 |
| Working Capital Turnover Ratio | -2.95 | 0.88 | 3.28 | 4.84 | 0.49 |
| Cash Conversion Cycle | 45.43 | 995.95 | 836.93 | 295.15 | 175.98 |
| Days of Sales Outstanding | 53.84 | 51.43 | 81.67 | 75.31 | 180.52 |
| Days of Inventory Outstanding | 831.65 | 1931.42 | 1646.53 | 1269.82 | 766.61 |
| Days of Payables Outstanding | 840.06 | 986.90 | 891.27 | 1049.99 | 771.15 |
| Operating Cycle | 885.49 | 1982.85 | 1728.20 | 1345.13 | 947.13 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5331.08 | -3491.86 | -2155.63 | -2831014.82 | -6589824.12 |
| Free Cash Flow Per Share | -5336.71 | -3519.31 | -2155.63 | -2974258.84 | -6590954.77 |
| Dividend Paid and CapEx Coverage Ratio | -947.44 | -127.20 | 0.00 | -19.76 | -5828.33 |
| Capital Expenditure Coverage Ratio | -947.44 | -127.20 | 0.00 | -19.76 | -5828.33 |
| Operating Cash Flow Coverage Ratio | -0.54 | -0.80 | -0.90 | -0.95 | -1.19 |
| Operating Cash Flow to Sales Ratio | -2.06 | -2.51 | -3.41 | -2.77 | -8.07 |
| Free Cash Flow Yield | -1091.69% | -398.22% | -2845.72% | -91269.93% | -16899.88% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.04 | -0.19 | -0.03 | -0.00 | -0.00 |
| Price-to-Sales (P/S) Ratio | 0.19 | 0.64 | 0.12 | 0.00 | 0.05 |
| Price-to-Book (P/B) Ratio | -0.13 | 1.02 | 0.24 | -0.06 | 0.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.09 | -0.25 | -0.04 | -0.00 | -0.01 |
| Price-to-Operating Cash Flow Ratio | -0.09 | -0.25 | -0.04 | -0.00 | -0.01 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | -0.87 | -0.98 | -0.97 | -0.88 | -0.30 |
| Enterprise Value | 44.81M | 35.96M | 31.79M | 29.40M | 12.52M |
| EV to EBITDA | -0.87 | -0.98 | -0.97 | -0.88 | -0.30 |
| EV to Sales | 3.89 | 3.08 | 3.26 | 2.46 | 2.89 |
| EV to Free Cash Flow | -1.89 | -1.21 | -0.96 | -0.85 | -0.36 |
| EV to Operating Cash Flow | -1.89 | -1.22 | -0.96 | -0.89 | -0.36 |
| Tangible Book Value Per Share | -7812.06 | -1424.24 | -986.90 | -2034920.18 | -2034798.99 |
| Shareholders’ Equity Per Share | -3891.29 | 865.72 | 321.70 | -56185.86 | 2188002.51 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 2590.82 | 1389.07 | 632.97 | 1022462.94 | 816896.98 |
| Net Income Per Share | -12026.56 | -4574.21 | -2678.17 | -4058209.81 | -9911118.09 |
| Tax Burden | 0.99 | 0.98 | 0.99 | 0.98 | 1.00 |
| Interest Burden | 1.00 | 1.01 | 1.24 | 1.36 | 1.19 |
| Research & Development to Revenue | 2.17 | 1.42 | 1.91 | 1.48 | 3.48 |
| SG&A to Revenue | 2.26 | 2.06 | 1.70 | 1.49 | 3.95 |
| Stock-Based Compensation to Revenue | -0.07 | 0.14 | 0.22 | 0.28 | 0.92 |
| Income Quality | 1.54 | 0.75 | 0.79 | 0.67 | 0.66 |
Currency in USD
